Steve Slilaty

Currently holds a position at Sunshine Biopharma Inc

Position	Company	Period
Chairman of the Board, President, Chief Executive Officer	Sunshine Biopharma Inc	Oct. 15, 2009 -

Sebaaly Camille

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2024-03-05	2024-03-04	Sunshine Biopharma Inc (SBFM)	B Purchase	67,457 +43.6% 41.17 US$1,960,668	67,457 +43.6%	41.17	US$1,960,668
2024-02-12	2024-02-08	Sunshine Biopharma Inc (SBFM)	B Purchase	36,679 +12.3% 181.84 US$2,003,530	36,679 +12.3%	181.84	US$2,003,530
2016-04-26	2016-04-12	Sunshine Biopharma Inc (SBFM)	B Purchase	21,274 -49.1% 489.44 US$580,254	21,274 -49.1%	489.44	US$580,254
2015-06-01	2015-05-27	Sunshine Biopharma Inc (SBFM)	B Purchase	500,000 +inf% 0.10 US$50,000	500,000 +inf%	0.10	US$50,000
2012-09-07	2012-09-04	Sunshine Biopharma Inc (SBFM)	S Sale	2,591,500 -7.6% 0.05 US$129,575	2,591,500 -7.6%	0.05	US$129,575